Noom vs Vyvron
Noom and Vyvron sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vyvron
Best for: seeing what it charges before you answer any medical questions
Visit Vyvron →If you are choosing between Noom and Vyvron, price alone will not settle it. Noom leads our six-part score, 6.9 to 5.2.
Noom vs Vyvron price
Noom and Vyvron start at the same figure, $179 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Medications and formats
Noom lists semaglutide and tirzepatide; Vyvron does not name its drug.
On format, Noom prices compounded injections and brand-name pens, while Vyvron posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.
Where each one treats patients
Neither Noom nor Vyvron publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Noom
The first 3 weeks of the program with 4 weeks of medication start from $149, then $349 per month plus tax on a 12-week subscription. The program also offers generic liraglutide.
The first 3 weeks with 4 weeks of medication start from $79, then $179 per month plus tax on a 12-week subscription. Compounded tirzepatide is also offered on this plan.
Vyvron
Founding-member rate of $149 per 4 weeks is locked for the life of the membership; the standing rate is $179. Vyvron does not state which medication this tier buys.
Founding-member rate of $199 per 4 weeks is locked for the life of the membership; the standing rate is $249. Vyvron does not state which medication this tier buys.
What each price covers
Noom's price also covers the clinician visit and coaching, which Vyvron does not claim.
Noom is silent on the medication itself, shipping and lab work.
Vyvron does not say what its price includes.
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Vyvron
Inclusions not disclosed.
Where each one scores higher
Overall, Noom scores 6.9 and Vyvron 5.2 out of 10.
Noom is stronger on value (5.2 vs 3.0) and effectiveness (10.0 vs 5.0).
Vyvron is stronger on support (5.0 vs 4.0).
User experience, trust & safety and accessibility are within half a point.
Noom
6.9/10
Vyvron
5.2/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Noom nor Vyvron has an FDA warning letter on record with us.
Features & Coverage
| Feature | Noom | Vyvron |
|---|---|---|
| Starting Price | $179/mo | $179/mo |
| Features | 2 features | ✓5 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →About Vyvron
Two membership tiers are on sale, $149 and $199 for each four-week period, both founding-member rates; they revert later to $179 and $249. The company states plainly that it is neither pharmacy nor medical practice, with pharmacy and clinical work running through OpenLoop Health plus the professional entities affiliated with it. Its LegitScript certification checks out, and the registration is Wyoming. Semaglutide and tirzepatide get named as possibilities, but no published price is ever attached to either.
Read our full Vyvron review →Pros & Cons
Noom
What we like
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Vyvron
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- We found no FDA warning letters issued to Vyvron
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Noom wins this one, 6.9 to 5.2, above all for coaching bundled into the price rather than sold separately. Vyvron fits better if seeing what it charges before you answer any medical questions is your priority.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $179 a month.
Choose Vyvron if…
You want seeing what it charges before you answer any medical questions and an opening price near $179 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →Noom vs Vyvron: FAQ
Close alternatives to Noom and Vyvron
- Noom vs GOAL.MD
- Noom vs Vaylen
- Noom vs DudeMeds
- Noom vs Healthicare
- Vyvron vs Nurx
- Vyvron vs Bodybuilding Health+
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.